Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C39H62N10O15S |
| Molecular Weight | 943.0352 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(O)=O
InChI
InChIKey=AGNIXLPCPQAPSB-SXHLWKDOSA-N
InChI=1S/C39H62N10O15S/c1-16(2)11-25(39(63)64)45-37(61)29(19(5)51)49-35(59)26(14-50)46-38(62)30(20(6)52)48-34(58)24(13-28(41)54)44-36(60)27(15-65)47-32(56)18(4)42-33(57)23(43-31(55)17(3)40)12-21-7-9-22(53)10-8-21/h7-10,16-20,23-27,29-30,50-53,65H,11-15,40H2,1-6H3,(H2,41,54)(H,42,57)(H,43,55)(H,44,60)(H,45,61)(H,46,62)(H,47,56)(H,48,58)(H,49,59)(H,63,64)/t17-,18-,19+,20+,23-,24-,25-,26-,27-,29-,30-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10284618
Created by
admin on Tue Apr 01 16:50:03 GMT 2025 , Edited by admin on Tue Apr 01 16:50:03 GMT 2025
|
PRIMARY | |||
|
465500-22-5
Created by
admin on Tue Apr 01 16:50:03 GMT 2025 , Edited by admin on Tue Apr 01 16:50:03 GMT 2025
|
PRIMARY | |||
|
PGQ5HC5AMU
Created by
admin on Tue Apr 01 16:50:03 GMT 2025 , Edited by admin on Tue Apr 01 16:50:03 GMT 2025
|
PRIMARY | |||
|
Survivin
Created by
admin on Tue Apr 01 16:50:03 GMT 2025 , Edited by admin on Tue Apr 01 16:50:03 GMT 2025
|
PRIMARY | The single survivin gene can give rise to four different alternatively spliced transcripts: Survivin-2B, which has an insertion of an alternative exon 2. |
ACTIVE MOIETY
